Response to RET-Specific Therapy in RET Fusion-Positive Anaplastic Thyroid Carcinoma

Background: Anaplastic thyroid carcinoma (ATC) remains one of the most challenging malignancies to treat in the modern era. Most patients present with or develop recurrent/metastatic incurable disease with poor response rates to conventional chemotherapy, and life expectancy is short. Next-generatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Dias-Santagata, Dora, Lennerz, Jochen K., Sadow, Peter M., Frazier, Ryan P., Govinda Raju, Sandya, Henry, Dahlia, Chung, Trisha, Kherani, Jennifer, Rothenberg, S. Michael, Wirth, Lori J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2020
Materias:
Case Studies, and Patients with Remarkable Features or Rare Disorders
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482117/
https://www.ncbi.nlm.nih.gov/pubmed/32292131
http://dx.doi.org/10.1089/thy.2019.0477

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482117/
https://www.ncbi.nlm.nih.gov/pubmed/32292131
http://dx.doi.org/10.1089/thy.2019.0477

Ejemplares similares